SMS Lifesciences India Ltd. logo

SMS Lifesciences India Ltd. (SMSLIFE)

Market Open
7 Aug, 10:00
XNSE XNSE
1,457. 40
+18.7
+1.2998%
2.14B Market Cap
43.44 P/E Ratio
6% Div Yield
391 Volume
0 Eps
1,438.7
Previous Close
Add Transaction
Day Range
1,431.6 1,469.6
Year Range
1,067 1,774
Want to track SMSLIFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SMSLIFE trading today higher at ₹1,457.4, an increase of 1.2998% from yesterday's close, completing a monthly decrease of -5.4373% or -₹83.8. Over the past 12 months, SMSLIFE stock gained 12.8805%.
SMSLIFE pays dividends to its shareholders, with the most recent payment made on Oct 30, 2025. The next estimated payment will be in In 2 months on Oct 30, 2026 for a total of ₹1.5.
The last earnings report, released on May 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).

SMSLIFE Chart

People also search for

GPT Healthcare Ltd.
157.85
+0.4518%
Sastasundar Ventures Ltd.
300.3
-0.9565%
Max India Limited
169.46
-0.9469%
Kokuyo Camlin Ltd.
83.98
-1.2116%
Sterling Tools Ltd.
222.5
-4.1568%

SMS Lifesciences India Ltd. (SMSLIFE) FAQ

What is the stock price today?

The current price is ₹1,457.40.

On which exchange is it traded?

SMS Lifesciences India Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is SMSLIFE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6%.

What is its market cap?

As of today, the market cap is 2.14B.

Has SMS Lifesciences India Ltd. ever had a stock split?

No, there has never been a stock split.

SMS Lifesciences India Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Talluri Veera Venkata Satyanarayana Murthy CEO
XNSE Exchange
Y806HA102 CUSIP
India Country
592 Employees
24 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

SMS Lifesciences India Limited is a company that specializes in the manufacturing and sales of active pharmaceutical ingredients (APIs) and intermediaries. Operating predominantly in India, this company serves a vital role in the pharmaceutical industry by providing essential components for various therapeutic areas. Since its inception in 1990, SMS Lifesciences has built a reputation for delivering high-quality products. Based in Hyderabad, India, the company has also expanded its reach by exporting its products to meet international demands. With its focus on innovation and quality, SMS Lifesciences India Limited continues to contribute significantly to the global pharmaceutical landscape.

Products and Services

  • Antiulcer - SMS Lifesciences India Limited offers APIs that are essential in the manufacture of medications designed to treat ulcer conditions, aiding in the relief of symptoms and promoting healing in patients.
  • Erectile Dysfunction - The company provides APIs for the development of drugs aimed at treating erectile dysfunction, helping in improving the quality of life for those affected by this condition.
  • Anti-gout - Specializing in APIs for anti-gout medications, SMS Lifesciences India Limited assists in the creation of treatments that help manage and alleviate the pain and inflammation associated with gout.
  • Anesthesia - The APIs produced for anesthesia are crucial for surgeries and procedures requiring pain suppression, ensuring patient comfort and procedural efficiency.
  • Anti-infective - By offering APIs for anti-infective drugs, the company supports the fight against infections, providing crucial components for medications that combat a variety of infectious diseases.
  • Anti-obesity - With a focus on the growing need for treatments addressing obesity, SMS Lifesciences India Limited offers APIs that are used in the production of anti-obesity drugs, aiding in weight management solutions.
  • Antifungal - The antifungal APIs from SMS Lifesciences are important for the development of medications aimed at treating fungal infections, ensuring effective relief and recovery for patients.
  • Anti-convulsant - Catering to the therapeutic area of epilepsy and other seizure disorders, the company's APIs for anti-convulsant drugs are essential for managing and treating these conditions.
  • Anti-emetic - Providing APIs for anti-emetic medications, SMS Lifesciences India Limited helps in the creation of treatments that effectively prevent nausea and vomiting, enhancing patient comfort.
  • Ophthalmic - Through their APIs for ophthalmic use, the company plays a significant role in the development of eye care medications, addressing various eye health issues.
  • Anti-worm - The company provides essential components for anti-worm medications, contributing to treatments that help in the eradication of worm infestations.
  • Antiemetic - Apart from its general anti-emetic offerings, the company also focuses on specific APIs that aid in the development of advanced antiemetic drugs, further reinforcing its commitment to comprehensive healthcare solutions.

Contact Information

Address: Plot No. 19-III
Phone: 91 40 6628 8888